| aa | Amino acid residue |
| ADP | Adenosine diphosphate |
| ALL | Acute lymphoblastic leukemia |
| APC | Antibody-PROTAC conjugate |
| AR | Androgen receptor |
| Arg | Arginine |
| BC | Breast cancer |
| BCR | B cell receptor |
| BET | Bromodomain and extra-terminal domain |
| BRD4 | Bromodomain-containing protein 4 |
| BTK | Bruton’s tyrosine kinase |
| CDK | Cyclin-dependent kinase complexes |
| CDK6 | Cyclin-dependent kinase 6 |
| CDK9 | Cyclin-dependent kinase 9 |
| CLIPTAC | In-cell click-formed Proteolysis Targeting Chimeras |
| CML | Chronic myeloid leukemia |
| CRBN | Cereblon |
| CRC | Colorectal cancer |
| DHT | Dihydroxytestosterone |
| DNA | Deoxyribonucleic acid |
| EGFR | Epidermal growth factor receptor |
| ERRα | Estrogen-related receptor α |
| FDA | Food and Drug Administration |
| HECT | Homologous to the E6AP carboxyl terminus |
| HER 2 | Human epidermal growth factor receptor 2 |
| HIF1α | Hypoxia-inducible factor-1α |
| HSP-90 | Heat shock protein 90 |
| IAP | Cellular inhibitor of apoptosis protein 1 |
| LK-Ph+ | Philadelphia chromosome positive chronic myeloid leukemia |
| mAb | Monoclonal antibodies |
| MCL1 | Induced myeloid leukemia cell differentiation protein |
| MDM2 | Mouse double minute 2 |
| MeBS | Bestatin |
| MetAP-2 | Methionine aminopeptidase-2 |
| MM | Multiple myeloma |
| mRNA | messenger RNA |
| Mut | Mutant |
| NAD+ | Nicotinamide-adenine dinucleotide |
| NHL | Non-Hodgkin’s lymphoma |
| NSCLC | Non-small cell lung cancer |
| PARP1 | Poly (ADP-ribose) polymerase-I |
| PARPs | Poly (ADP-ribose) polymerases enzyme |
| PC | Prostate cancer |
| PDP | Protein Degradation Probe |
| PEG | Polyethylene glycol |
| PIK3C3 | Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 |
| PKB | Protein kinase B |
| POI | Protein of interest |
| Poly-Ub | Polyubiquitin |
| PROTAC | PROteolysis-TArgeting Chimera |
| PROTAP | PROteolysis TArgeting Peptide |
| RARα | Retinoic acid receptor alpha |
| RBR | RING1-in-between-RING 2 |
| RING | Really Interesting New Gene |
| RNAi | RNA interference |
| Ro5 | Lipinski’s Rule of Five |
| SARM | Selective androgen receptor modulator |
| SMI | Small molecule inhibitors |
| SNIPPER | Specific and Non-genetic IAP-dependent Protein ERaseR |
| TNBC | Triple negative breast cancer |
| TPD | Targeted protein degradation |
| TrkC | Tropomyosin receptor kinase C |
| Ub | Ubiquitin |
| USP | Ubiquitin-proteasome system |
| VHL | Von Hippel-Lindau |